For example, IGHV4-39 of AML-Igμ had a higher proportion of potential N-glycosylation sites (21/39, 53.8%) than that of B-Igμ (11/64, 17.2%) in AML14 (Figure 5A). Here, CD40LG is linked to acute myeloid leukemia.